Compare Home Depot Inc (HD) vs Medpace Holdings Inc (MEDP) Price & Performance

Home Depot (HD) trades at $344.63, down 1.75% on the day, with a bullish technical outlook from moving averages but overbought RSI signals. Recent earnings show mixed quarterly beats, with Q2 2026 results pending. Revenue grew to $159.51 billion in 2025, though net margins have declined to 8.41%. The stock benefits from strong analyst support, with a consensus price target of $371.25, and a dividend payment scheduled for June 2026.

The stock presents a long-term opportunity driven by Pro customer growth and housing tailwinds, but faces risks from weakening big-ticket demand and margin pressures. With 59% of analysts rating it a buy, upside exists if earnings rebound, though high valuation multiples and economic sensitivity warrant caution.

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.